Coupland NJ, Bell CJ and Potokar JP (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16:356 –362.
DeVane CL (1994) Pharmacokinetics of the newer antidepressants: Clinical relevance. Am J Med 97 (Suppl 6A):13S–23S.
Fields TA and Casey PJ (1995) Phosphorylation of Gz alpha by protein kinase C
blocks interaction with the beta gamma complex. J Biol Chem 270:23119 –23125.
Fuller RW (1996) Mechanisms and functions of serotonin neuronal systems—
Opportunities for neuropeptide interactions. Ann NY Acad Sci 780:176 –184.
Gardier AM, Lepoul E, Trouvin JH, Chanut E, Dessalles MC and Jacquot C (1994)
Changes in dopamine metabolism in rat forebrain regions after cessation of longterm fluoxetine treatment: Relationship with brain concentrations of fluoxetine
and norfluoxetine. Life Sci 54:PL51–PL56.
Gilbert F, Brazell C, Tricklebank MD and Stahl SM (1988) Activation of the 5-HT1A
receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol
147:431– 439.
Hallak H, Brass LF and Manning DR (1994) Failure to myristoylate the alpha
subunit of Gz is correlated with an inhibition of palmitoylation and membrane
attachment, but has no effect on phosphorylation by protein kinase C. J Biol Chem
269:4571– 4576.
Ho MK and Wong YH (1997) Functional role of amino-terminal serine16 and
serine27 of G alphaZ in receptor and effector coupling. J Neurochem 68:2514 –
2522.
Kreiss DS and Lucki I (1995) Effects of acute and repeated administration of
antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in
vivo. J Pharmacol Exp Ther 274:866 – 876.
Le Poul E, Laaris N, Doucet E, Laporte A-M, Hamon M and Lanfumey L (1995) Early
desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with
fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 352:141–148.
Lerer B, Gelfin Y and Gorfine M (1997) Temperature and hormone responses of
normal subjects to ipsapirone challenge: Effect of fluoxetine treatment. Psychoneuroendocrinology 22:166.
Lesch KP, Schulte HM, Osterheider M and Muller T (1991) Long-term fluoxetine
treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 105:415– 420.
Levy AD, Li Q, Gustafson M and Van de Kar LD (1995) Neuroendocrine profile of the
potential anxiolytic drug S-20499. Eur J Pharmacol 274:141–149.
Li Q, Brownfield MS, Battaglia G, Cabrera TM, Levy AD, Rittenhouse PA and Van
de Kar LD (1993a) Long-term treatment with the antidepressants fluoxetine and
desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2- [1-piperazinyl]-pyrazine (MK-212) and (6)-1-(2,5-dimethoxy-4-iodophenyl)-2- aminopropane HCI (DOI). J Pharmacol Exp Ther 266:836 – 844.
Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G and Van de Kar LD (1993b)
Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin re- sponses to the 5-HT1A agonist 8-OH-DPAT in male rats. Brain Res 630:148 –156.
Li Q, Brownfield MS, Levy AD, Battaglia G, Cabrera TM and Van de Kar LD (1994)
Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term
treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry
36:300 –308.
Li Q, Muma NA and Van de Kar LD (1996) Chronic fluoxetine induces a gradual
desensitization of 5-HT1A receptors: Reductions in hypothalamic and midbrain Gi
and Go proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther 279:1035–1042.
Li Q, Muma NA, Battaglia G and Van de Kar LD (1997) A desensitization of
hypothalamic 5-HT1A receptors by repeated injections of paroxetine: Reduction in
the levels of Gi and Go proteins and neuroendocrine responses, but not in the
density of 5-HT1A receptors. J Pharmacol Exp Ther 282:1581–1590.
Raap DK, Garcia F, Battaglia G, Muma NA and Van de Kar LD (1997) Withdrawal
from chronic fluoxetine produces a gradual reversal of desensitization of 5-HT1A
receptor-mediated neuroendocrine responses to 8-OH-DPAT. Soc Neurosci Abst
23:385.5.
